Fåhraeus Startup and Growth | FSG
Follow us
Reach out to Fåhraeus Startup and Growth | FSG
About Fåhraeus Startup and Growth | FSG
Themes
Funding Stages
Who we are
FSG (Fåhraeus Startup and Growth) is a venture capital fund based in Lund, Sweden, founded in 2021. We have 26 portfolio companies across the Nordics, and our first exit was SAGA Diagnostics, acquired by Roche in 2026. FSG Fund II is backed by the European Investment Fund (EIF) under InvestEU.Funding Requirements
We invest €1–6M from Seed to Series A in Nordic companies at the intersection of life science and tech: digital health, healthtech, healthcare software, medtech, connected medical devices, diagnostics and life science tools. Therapeutics selectively, in clinically de-risked phases. We back commercial-stage companies with clear signs of product-market fit.Value add
We are hands-on, long-term partners to founders. Our team combines serial entrepreneurship with investment experience, and we bring sector expertise in life science, healthcare and technology, a strong network of operators and strategic partners, and practical help with growth, hiring, partnerships and fundraising.Locations
Founder Reviews Of Fåhraeus Startup and Growth | FSG
No reviews yet
Write The First ReviewSimilar Investors
VC firm
Incubator & Accelerator
Angel group
Featured in Investor Lists
OpenVC has more than 10,000 investor profiles like this one.
Discover how each investor thinks, what they fund, and whether they’re the right fit for your startup.
Are you sure you want to contact this investor ?
Sweden
Norway
Denmark
Finland
Brazil
China
Germany
France
Canada
Colombia
Malaysia
USA
Austria